NM_006922.4:c.2077A>G

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_006922.4(SCN3A):​c.2077A>G​(p.Met693Val) variant causes a missense change. The variant allele was found at a frequency of 0.000172 in 1,613,980 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M693T) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00019 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00017 ( 0 hom. )

Consequence

SCN3A
NM_006922.4 missense

Scores

1
6
12

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:2

Conservation

PhyloP100: 3.83

Publications

1 publications found
Variant links:
Genes affected
SCN3A (HGNC:10590): (sodium voltage-gated channel alpha subunit 3) Voltage-gated sodium channels are transmembrane glycoprotein complexes composed of a large alpha subunit with 24 transmembrane domains and one or more regulatory beta subunits. They are responsible for the generation and propagation of action potentials in neurons and muscle. This gene encodes one member of the sodium channel alpha subunit gene family, and is found in a cluster of five alpha subunit genes on chromosome 2. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
SCN3A Gene-Disease associations (from GenCC):
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: Illumina, ClinGen
  • developmental and epileptic encephalopathy, 62
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • epilepsy, familial focal, with variable foci 4
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • undetermined early-onset epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.015026331).
BP6
Variant 2-165139551-T-C is Benign according to our data. Variant chr2-165139551-T-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 547844.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00019 (29/152294) while in subpopulation SAS AF = 0.00414 (20/4826). AF 95% confidence interval is 0.00275. There are 0 homozygotes in GnomAd4. There are 19 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 29 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SCN3ANM_006922.4 linkc.2077A>G p.Met693Val missense_variant Exon 14 of 28 ENST00000283254.12 NP_008853.3 Q9NY46-3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SCN3AENST00000283254.12 linkc.2077A>G p.Met693Val missense_variant Exon 14 of 28 1 NM_006922.4 ENSP00000283254.7 Q9NY46-3

Frequencies

GnomAD3 genomes
AF:
0.000191
AC:
29
AN:
152176
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00414
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000588
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000342
AC:
86
AN:
251180
AF XY:
0.000442
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000123
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.000170
AC:
248
AN:
1461686
Hom.:
0
Cov.:
30
AF XY:
0.000235
AC XY:
171
AN XY:
727142
show subpopulations
African (AFR)
AF:
0.0000598
AC:
2
AN:
33460
American (AMR)
AF:
0.00
AC:
0
AN:
44708
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26128
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39688
South Asian (SAS)
AF:
0.00232
AC:
200
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53408
Middle Eastern (MID)
AF:
0.000520
AC:
3
AN:
5766
European-Non Finnish (NFE)
AF:
0.0000279
AC:
31
AN:
1111882
Other (OTH)
AF:
0.000182
AC:
11
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
16
32
48
64
80
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000190
AC:
29
AN:
152294
Hom.:
0
Cov.:
32
AF XY:
0.000255
AC XY:
19
AN XY:
74464
show subpopulations
African (AFR)
AF:
0.000120
AC:
5
AN:
41576
American (AMR)
AF:
0.00
AC:
0
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5166
South Asian (SAS)
AF:
0.00414
AC:
20
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000588
AC:
4
AN:
68028
Other (OTH)
AF:
0.00
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000927
Hom.:
0
Bravo
AF:
0.0000453
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000233
AC:
2
ExAC
AF:
0.000412
AC:
50
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00
EpiControl
AF:
0.000119

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:1
Jan 11, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 02, 2016
Mayo Clinic Laboratories, Mayo Clinic
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

SCN3A-related disorder Benign:1
Feb 04, 2022
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.068
BayesDel_addAF
Uncertain
0.014
T
BayesDel_noAF
Pathogenic
0.24
CADD
Benign
21
DANN
Benign
0.64
DEOGEN2
Uncertain
0.49
T;.;.;.;.
Eigen
Benign
-0.17
Eigen_PC
Benign
0.040
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Benign
0.84
T;T;T;T;T
M_CAP
Benign
0.044
D
MetaRNN
Benign
0.015
T;T;T;T;T
MetaSVM
Uncertain
0.27
D
MutationAssessor
Benign
1.5
L;L;.;.;.
PhyloP100
3.8
PrimateAI
Uncertain
0.58
T
PROVEAN
Benign
-2.2
N;N;.;N;N
REVEL
Uncertain
0.59
Sift
Benign
0.22
T;T;.;T;T
Sift4G
Benign
0.62
T;T;.;T;T
Polyphen
0.025
B;B;.;B;B
Vest4
0.24
MVP
0.80
MPC
0.50
ClinPred
0.065
T
GERP RS
5.7
Varity_R
0.32
gMVP
0.51
Mutation Taster
=38/62
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs138331141; hg19: chr2-165996061; API